Nafithromycin’s efficacy stands out as it targets both typical and atypical pathogens, offering a potent solution where no new antibiotic in this class has been developed worldwide for over ...

India has launched the first indigenous antibiotic for drug-resistant infections. Known as 'Nafithromycin,' the drug has been developed by researchers from the Biotechnology Industry Research ...

The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for the Community-Acquired Bacterial Pneumonia (CABP) in Adults ...